塞沃弗劳兰通过BDNF-TrkB通路产生抗抑郁药类效应
Shaohua You1, Yishuang Wu2, Yongxin Guo3
1Department of Anesthesia, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China; Department of Pain Medicine, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
Behavioural brain research
|February 22, 2024
概括
麻醉剂Sevoflurane通过影响来自大脑的神经营养因子 (BDNF) - 铁素受体激酶B (TrkB) 途径,在小鼠中表现出类似抗抑郁药的作用. 通过观察TrkB通路操纵后的行为变化和蛋白质表达来证实这种效应.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抑郁症是全球领先的精神疾病之一.
- 麻醉剂已经显示出潜在的抗抑郁药特性.
- 塞沃兰的特定抗抑郁作用尚未得到充分证实.
研究的目的:
- 为了研究sevoflurane在小鼠中的类似抗抑郁药的作用.
- 为了探索大脑衍生神经营养因子 (BDNF) - 铁素受体激酶B (TrkB) 途径在赛沃兰作用中的作用.
- 为了确定sevoflurane的抗抑郁作用是否由BDNF-TrkB途径调解.
主要方法:
- 行为测试 (开放场地,强迫游泳,新鲜感抑制的养) 用于评估小鼠的焦虑和抑郁类行为.
- 西方涂抹被用来分析海马和前额叶皮层中的蛋白质表达.
- 使用通过侧腔室微注射输送的小干扰RNA (siRNA) 下调TrkB受体表达.
主要成果:
- 在小鼠中,吸入2.5%的黄显著减少了类似抑郁症的行为.
- 吸入sevoflurane导致海马体和前额皮层中酸化TrkB (p-TrkB) 表达的增加.
- 当TrkB表达被下调时,sevoflurane的抗抑郁药效应被废除了.
结论:
- 塞沃弗卢兰具有显著的抗抑郁药类效应.
- 这些效应通过脑衍生神经营养因子 (BDNF) - 铁素受体激酶B (TrkB) 信号通路进行介导.
- 塞沃弗兰代表了抑郁症治疗的潜在治疗途径.
更多相关视频
相关概念视频
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
174
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
174
01:23Antidepressant Drugs: MAOIs and Other Agents
230
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
230